ATE305140T1 - Verfahren zur detektion der hk2 polypeptide - Google Patents

Verfahren zur detektion der hk2 polypeptide

Info

Publication number
ATE305140T1
ATE305140T1 AT97934958T AT97934958T ATE305140T1 AT E305140 T1 ATE305140 T1 AT E305140T1 AT 97934958 T AT97934958 T AT 97934958T AT 97934958 T AT97934958 T AT 97934958T AT E305140 T1 ATE305140 T1 AT E305140T1
Authority
AT
Austria
Prior art keywords
polypeptides
detecting
prostate
antigen
phk2
Prior art date
Application number
AT97934958T
Other languages
English (en)
Inventor
Mohammad Saeed Saedi
Stephen D Mikolajczyk
Lana Grauer
Donald J Tindall
Charles Y F Young
George G Klee
Original Assignee
Mayo Foundation
Hybritech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayo Foundation, Hybritech Inc filed Critical Mayo Foundation
Application granted granted Critical
Publication of ATE305140T1 publication Critical patent/ATE305140T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6445—Kallikreins (3.4.21.34; 3.4.21.35)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57555—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96455—Kallikrein (3.4.21.34; 3.4.21.35)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT97934958T 1996-07-15 1997-07-15 Verfahren zur detektion der hk2 polypeptide ATE305140T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68086896A 1996-07-15 1996-07-15
PCT/US1997/012322 WO1998002748A1 (en) 1996-07-15 1997-07-15 Methods to detect hk2 polypeptides

Publications (1)

Publication Number Publication Date
ATE305140T1 true ATE305140T1 (de) 2005-10-15

Family

ID=24732858

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97934958T ATE305140T1 (de) 1996-07-15 1997-07-15 Verfahren zur detektion der hk2 polypeptide

Country Status (7)

Country Link
EP (1) EP0974057B1 (de)
JP (1) JP3955636B2 (de)
AT (1) ATE305140T1 (de)
AU (1) AU736419B2 (de)
CA (1) CA2261019A1 (de)
DE (1) DE69734249T2 (de)
WO (1) WO1998002748A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6479263B1 (en) 1996-11-14 2002-11-12 Baylor College Of Medicine Method for detection of micrometastatic prostate cancer
WO1998059073A1 (en) 1997-06-20 1998-12-30 Mayo Foundation For Medical Education And Research Method for detection of breast cancer
EP2080802B1 (de) * 1998-06-01 2017-03-29 Agensys, Inc. Neuartige serpentine-transmembran-antigene, die von krebserkrankungen des menschen exprimiert werden, und verwendungen davon
US8663600B2 (en) * 2005-02-17 2014-03-04 Diaprost Ab Diagnosis of prostate cancer
EP2913405B1 (de) 2010-07-27 2016-11-09 Genomic Health, Inc. Verfahren zur Verwendung von Genexpression zur Bestimmung der Prognose von Prostatakrebs
CN114375302B (zh) 2019-07-26 2024-12-24 詹森生物科技公司 包含激肽释放酶相关肽酶2抗原结合结构域的蛋白质及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3684578D1 (de) * 1985-12-17 1992-04-30 Eastern Virginia Medical Autho Monoklonale antikoerper mit bindungsspezifitaet fuer menschliche prostatatumorantigene und methoden fuer ihre verwendung.
US5516639A (en) * 1993-07-22 1996-05-14 Mayo Foundation For Medical Education And Research Antibodies specific for human prostate glandular kallkrein
US6103237A (en) * 1993-07-22 2000-08-15 Hybritech Incorporated Stable variant hK2 polypeptide
EP0804593A1 (de) * 1994-05-10 1997-11-05 Mayo Foundation For Medical Education And Research Rekombinantes hk2 polypeptid
GB2302874B (en) * 1995-06-29 1999-11-10 Orion Yhtymae Oy Novel proteins

Also Published As

Publication number Publication date
JP3955636B2 (ja) 2007-08-08
DE69734249D1 (de) 2006-02-02
EP0974057B1 (de) 2005-09-21
EP0974057A1 (de) 2000-01-26
CA2261019A1 (en) 1998-01-22
WO1998002748A1 (en) 1998-01-22
AU3800697A (en) 1998-02-09
AU736419B2 (en) 2001-07-26
JP2001500251A (ja) 2001-01-09
DE69734249T2 (de) 2006-07-13

Similar Documents

Publication Publication Date Title
EP0914155A4 (de) Spezifische monoklonale antikörperfür die extrazelluläre domäne von protasta-spezifischem membranantigen
DE59903915D1 (de) Verfahren zur frühen diagnose von carcinomen
ATE403001T1 (de) Antigenbindungsfragmente die spezifisch krebszellen nachweisen, nukleotide die für diese fragmente kodieren, und deren verwendung zur vorbeugung und zum nachweis von krebs
TR200000113T2 (tr) Tüberkülozu teşhis etmek için bileşikler ve bunları kullanma yöntemleri.
MX9801687A (es) Compuestos y metodos para el diagnostico de tuberculosis.
ATE386117T1 (de) Prostattumor polynukleotid- und antigenzusammensetzungen
HUP9701717A2 (hu) Eljárás cPSA-meghatározására
ES2137354T3 (es) Moleculas de anticuerpo anti-vla4 recombinante.
ATE98776T1 (de) Monoklonale antikoerper fuer hba1c.
BG101024A (bg) Моноклонално антитяло срещу сd44v6
DE60129151D1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
ATE412756T1 (de) Verfahren zur krebsdiagnose mittels eines chimärischen toxin
ES2142070T3 (es) Utilizacion de un complejo ficobiliproteina-peptido de enlace como trazador fluorescente.
DE69734249D1 (de) Verfahren zur detektion der hk2 polypeptide
DE69114339D1 (de) Verfahren zur Identifizierung oder Bestimmung von Proteinen und Verwendungen dazu.
ATE48037T1 (de) Verfahren und reagenz zur verwendung zur bestimmung von pivka-ii.
ID19063A (id) Pereaksi peptida untuk deteksi cytomegalovirus (cmv)
WO2000032635A3 (en) Tumor specific human monoclonal antibodies and methods of use
ES8501630A1 (es) Un metodo para detectar o vigilar el estado de una condicion patologica humana que implica proteina de tejido conjuntivo.
DK0495910T3 (da) Fremstilling og anvendelse af humant nm23-H2-protein og derimod rettede antistoffer
ATE221996T1 (de) Prostatakrebs- spezifischer antikörper für immundetektion und immuntherapie
ATE130100T1 (de) Verfahren zur immunologischen erkennung maligner tumore und kit zur durchführung dieses verfahrens.
ES8802196A1 (es) Metodo para determinar la presion de un estado maligno en tejidos.
DE69930843D1 (de) Verfahren zum bestimmen von autoantikörpern
DE69229948D1 (de) hGPIIb-FRAGMENTE UND IHRE VERWENDUNG IN IN-VITRO-VERFAHREN ZUR BESTIMMUNG VON IN VIVO STATTFINDENDEN THROMBOTISCHEN EREIGNISSEN

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties